Matsumoto K,
Fujimori N, Ichihara K, Takeno A, Murakami M, Ohno A, Kakehashi S, Teramatsu K, Ueda K, Nakata K, Sugahara O, Yamamoto T, Matsumoto A, Nakayama KI, Oda Y, Nakamura M, Ogawa Y.
Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction.
J Gastroenterol. 2024 Apr 29. doi: 10.1007/s00535-024-02103-0. Online ahead of print.
Murakami M,
Fujimori N, Takamatsu Y, Ito T, Matsumoto K, Kakehashi S, Ohno A, Teramatsu K, Ueda K, Ishigami K and Ogawa Y.
Efficacy and safety of streptozocin-based chemotherapy for gastroenteropancreatic neuroendocrine tumors in Japanese clinical practice
Jpn J Clin Oncol. 2024 Feb 29:hyae026. Online ahead of print.
Takikawa T, Kikuta K, Sano T, Ikeura T,
Fujimori N, Umemura T, Naitoh I, Nakase H, Isayama H, Kanno A, Kamata K, Kodama Y, Inoue D, Ido A, Ueki T, Seno H, Yasuda H, Iwasaki E, Nishino T, Kubota K, Arizumi T, Tanaka A, Uchida K, Matsumoto R, Hamada S, Nakamura S, Okazaki K, Takeyama Y, Masamune A; Japan Pancreatitis Study Group for AIP.
Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: A multicenter cohort study in Japan
Pancreatology. 2024 Jan 19:S1424-3903(24)00023-1. Online ahead of print.
Shibata K,
Fujimori N, Oono T, Motooka D, Okuzaki D, Sonoda K, Ogawa Y, Yamasaki S.
Single-cell analysis for identification of T-cell clonotypes associated with IgG4 production of autoimmune pancreatitis.
Gastroenterol Rep (Oxf). 2023 Dec 8:11:goad071. doi: 10.1093/gastro/goad071. eCollection 2023.
Ishiwatari H, Kawabara T, Kawashima H, Nakai Y, Miura S, Kato H, Shiomi H,
Fujimori N, Ogura T, Inatomi O, Kubota K, Fujisawa T, Takenaka M, Mori H, Noguchi K, Fujii Y, Sugiura T, Ideno N, Nakafusa T, Masamune A, Isayama H, Sasahira N.
Endoscopic nasobiliary drainage versus endoscopic biliary stenting for preoperative biliary drainage in patients with malignant hilar biliary obstruction: A propensity score matched multicenter comparative study
Dig Endosc. 2023 Oct 27. doi: 10.1111/den.14712. Online ahead of print.
Mizuno N, Ioka T, Ogawa G, Nakamura S, Hiraoka N, Ito Y, Katayama S< Takada R, Kobayashi S, Ikeda M, Muwa H, Okano N, Kuramochi H, Sekimoto M, Okusaka T, Ozaka M, Todaka A, Gotoh K, Tobimatsu K, Yamaguchi H, Nakagohri T, Kajiura S, Sudo K, Okamura K, Shimizu S, Shirakawa H, Kato N, Sano K, Iwai T,
Fujimori N, Ueno M, Ishii H, Furuse J and Hepatobiliary and Pancreatic Oncology Group (HBPOG) of Japan Clinical Oncology Group (JCOG)
Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgroup analysis on systemic inflammatory response in JCOG1106
Jpn J Clin Oncol. 2023 Jul 31;53(8):704-713. doi: 10.1093/jjco/hyad044.
Murakami M,
Fujimori N, Nakata K, Nakamura M, Hashimoto S, Kurahara H, Nishihara K, Abe T, Hashigo S, Kugiyama N, Ozawa E, Okamoto K, Ishida Y, Okano K, Takaki R, Shimamatsu Y, Ito T, Miki M, Oza N, Yamaguchi D, Yamamoto H, Takedomi H, Kawabe K, Akashi T, Miyahara K, Ohuchida J, Ogura Y, Nakashima Y, Ueki T, Ishigami K, Umakoshi H, Ueda K, Oono T, Ogawa Y.
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2
J Gastroenterol. 2023 Jun;58(6):586-597. doi: 10.1007/s00535-023-01987-8. Epub 2023 Apr 26.
Ikenaga N, Nakata K, Abe T, Ideno N,
Fujimori N, Oono T, Fujita N, Ishigami K, Nakamura M.
Risks and benefits of pancreaticoduodenectomy in patients aged 80 years and over
Langenbecks Arch Surg. 2023 Feb 27;408(1):108. doi: 10.1007/s00423-023-02843-2.
Nakachi K, Ikeda M, Konishi M, Nomura S, Katayama H, Kataoka T, Todaka A, Yanagimoto H, Morinaga S, Kobayashi S, Shimada K, Takahashi Y, Nakagohri T, Gotoh K, Kamata K, Shimizu Y, Ueno M, Ishii H, Okusaka T, Furuse J, Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial
Lancet. 2023 Jan 21; 401(10372):195-203. doi: 10.1016/S0140-6736(22)02038-4.
Ikenaga N, Nakata K, Hayashi M, Nakamura S, Abe T, Ideno N, Murakami M,
Fujimori N, Fujita N, Isoda T, Baba S, Ishigami K, Oda Y, Nakamura M.
Clinical Implications of FDG PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy
J Gastrointest Surg. 2023 Jan 18. doi: 10.1007/s11605-023-05591-2.
Ohno A,
Fujimori N, Kaku T, Takamatsu Y, Matsumoto K, Murakami M, Teramatsu K, Takeno A, Hijioka M, Kawabe K, Harada N, Nakamuta M, Aso A, Oono T, Ogawa Y.
Feasibility and Efficacy of Endoscopic Ultrasound-Guided Hepaticogastrostomy Without Dilation: A Propensity Score Matching Analysis.
Dig Dis Sci. 2022 Dec;67(12):5676-5684. doi: 10.1007/s10620-022-07555-z. Epub 2022 Jun 10.
Ohno A,
Fujimori N, Kaku T, Hijioka M, Kawabe K, Harada N, Nakamuta M, Oono T, Ogawa Y.
The feasibility of percutaneous transhepatic gallbladder aspiration for acute cholecystitis after self-expandable metallic stent placement for malignant biliary obstruction: a 10-year retrospective analysis in a single center.
Clin Endosc. 2022 Nov;55(6):784-792. doi: 10.5946/ce.2021.244. Epub 2022 Oct 21.
Miyagahara T,
Fujimori N, Ueda K, Takamatsu Y, Matsumoto K, Teramastu K, Takaoka T, Suehiro Y, Shimokawa Y, Omori K, Niina Y, Tachibana Y, Akashi T, Oono T, Ogawa Y.
Incidence and appropriate management of drug-induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospective study.
Asia Pac J Clin Oncol. 2023 Aug;19(4):533-541. doi: 10.1111/ajco.13903.
Minaga K, Kitano M, Uenoyama Y, Hatamaru K, Shiomi H, Ikezawa K, Miyagahara T, Imai H,
Fujimori N, Matsumoto H, Shimokawa Y, Masuda A, Takenaka M, Kudo M, Chiba Y.
Feasibility and efficacy of endoscopic reintervention after covered metal stent placement for EUS-guided hepaticogastrostomy: A multicenter experience.
Endosc Ultrasound. 2022 Nov-Dec;11(6):478-486. doi: 10.4103/EUS-D-22-00029.
Minoda Y, Esaki M, Ihara E, Nagatomo S, Nishioka K,
Fujimori N, Ogino H, Bai X, Tanaka Y, Chinen T, Hu Q, Ota M, Umekita S, Yamamoto H, Ogawa Y.
Auxiliary diagnosis of subepithelial lesions by impedance measurement during endoscopic ultrasound guided fine-needle biopsy.
Gastrointest Endosc. 2022 Nov 29:S0016-5107(22)02197-6. doi: 10.1016/j.gie.2022.11.022.
Shibata K. Motozono C, Nagae M, Shimizu T, Ishikawa E, Motooka D, Okuzaki D, Izumi Y, Takahashi M,
Fujimori N, Wing JB, Hayano T, Asai Y, Bamba T, Ogawa Y, Furutani-Seiki Makoto, Shirai M, Yamasaki S.
Symbiotic bacteria-dependent expansion of MR1-reactive T cells causes autoimmunity in the absence of Bcl11b
Nat Commun. 2022 Nov 14;13(1):6948.doi: 10.1038/s41467-022-34802-8.
Teramatsu K, Oono T, Oyama K,
Fujimori N, Murakami M, Yasumori S, Ohno A, Matsumoto K, Takeno A, Nakata K, Nakamura M, Ogawa Y.
Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer
BMC Cancer. 2022 Nov 4;22(1):1134. doi: 10.1186/s12885-022-10207-0.
Ishiwatari H, Kawabata T, Kawashima H, Nakai Y, Miura S, Kato H, Shiomi H,
Fujimori N, Ogura T, Inatomi O, Kubota K, Fujisawa T, Takenaka M, Mori H, Noguchi K, Fujii Y, Sugiura T, Ideno N, Nakafusa T, Masamune A, Isayama H, Sasahira N.
Clinical Outcomes of Inside Stents and Conventional Plastic Stents as Bridge-to-Surgery Options for Malignant Hilar Biliary Obstruction.
Dig Dis Sci. 2023 Apr;68(4):1139-1147. doi: 10.1007/s10620-022-07718-y.
Minoda Y, Ihara E,
Fujimori N, Nagatomo S, Esaki M, Hata Y, Bai X, Tanaka Y, Ogino H, Chinen T, Hu Q, Oki E, Yamamoto H, Ogawa Y.
Efficacy of ultrasound endoscopy with artificial intelligence for the differential diagnosis of non-gastric gastrointestinal stromal tumors.
Sci Rep 2022 Oct 5;12(1):16640. doi: 10.1038/s41598-022-20863-8.
Minoda Y, Ihara E, Itaba S, Sumida Y, Haraguchi K, Aso A, Mizutani T, Osoegawa T, Esaki M, Nagatomo S, Nishioka K, Muta K, Bai X, Ogino H,
Fujimori N, Tsurumaru D, Ohuchida K, Qingjiang H, Oki E, Yamamoto H, Ogawa Y.
Negligible procedure-related dissemination risk of mucosal incision-assisted biopsy for gastrointestinal stromal tumors versus endoscopic ultrasound-guided fine-needle aspiration/biopsy.
Surg Endosc. 2022 (in press) Jul 15. doi: 10.1007/s00464-022-09419-z.
Takamatsu Y,
Fujimori N, Miyagahara T, Suehiro Y, Kaku T, Kawabe K, Ohno A, Matsumoto K, Murakami M, Teramatsu K, Takeno A, Oono T, Ogawa Y.
The Glasgow Prognostic Score and stricture site can predict prognosis after endoscopic duodenal stent placement for malignant gastric outlet obstruction.
Sci Rep. 2022 Jun 13;12(1):9746. doi: 10.1038/s41598-022-13209-x.
Matsumoto K,
Fujimori N, Hata Y, Minoda Y, Murakami M, Teramatsu K, Takamatsu Y, Takeno A, Oono T, Ihara E, Nakata K, Nakamura M, Yamamoto T, Koga Y, Oda Y, Ito T, Ogawa Y.
Ampullary Neuroendocrine Neoplasm: Clinicopathological Characteristics and Novel Endoscopic Entity.
Dig Dis. 2023;41(2):316-324.. doi: 10.1159/000525013.
Murakami M,
Fujimori N, Matsumoto K, Ohno A, Teramatsu K, Takamatsu Y, Takeno A, Ueda K, Oono T, Ito T, Ogawa Y.
A clinical analysis on functioning pancreatic neuroendocrine tumors (focusing on VIPomas): a singlecenter experience.
Endocr J. 2022 Oct 28;69(10):1201-1209. doi: 10.1507/endocrj.EJ22-0111.
Murakami M,
Fujimori N, Ohno A, Matsumoto K, Teramatsu K, Takamatsu Y, Takeno A, OonoT, Abe T, Ideno N, Ikenaga N, Nakata K, Nakamura M, Ishigami K, Ogawa Y.
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: A single-center retrospective study
Discover Oncology, vol13(1) 2022
Ito T, Masui T, Komoto I, Doi R, Osamura RY, Sakurai A, Ikeda M, Takano K, Igarashi H, Shimatsu A, Nakamura K, Nakamoto Y, Hijioka S, Morita K, Ishikawa Y, Ohike N, Kasajima A, Kushima R, Kojima M, Sasano H, Hirano S, Mizuno N, Aoki T, Aoki T, Ohtsuka T, Okumura T, Kimura Y, Kudo A, Konishi T, Matsumoto I, Kobayashi N,
Fujimori N, Honma Y, Morizane C, Uchino S, Horiuchi K, Yamasaki M, Matsubayashi J, Sato Y, Sekiguchi M, Abe S, Okusaka T, Kida M, Kimura W, Tanaka M, Majima Y, Jensen RT, Hirata K, Imamura M, Uemoto S.
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
J Gastroenterol. 2021 Nov;56(11):1033-1044. doi: 10.1007/s00535-021-01827-7
Okuno H, Ogino H, Ihara E, Nishioka K, Tanaka Y, Chinen T, Kohjima M, Oono T, Tanaka M, Goya T,
Fujimori N, Iboshi Y, Gotoda T, Ogawa Y.
Discriminant equation using mucosally expressed cytokines and transcription factor for making definite diagnosis of inflammatory bowel disease unclassified
BMC Gastroenterol. 2021 Feb 16;21(1):73. doi: 10.1186/s12876-021-01656-1.
Fujimori N, Osoegawa T, Aso A, Itaba S, Minoda Y, Murakami M, Matsumoto K, Teramatsu K, Takamatsu Y, Takaoka T, Oono T, Ihara E, Yoshizumi T, Ohtsuka T, Nakamura M, Ogawa Y.
Efficacy of early endoscopic ultrasound-guided transluminal drainage for postoperative pancreatic fistula
Can J Gastroenterol Hepatol. 25;2021:6691705. eCollection 2021
Minaga K, Takenaka M, Ogura T, Tamura T, Kuroda T, Kaku T, Uenoyama Y, Noguchi C, Nishikiori H, Imai H, Sagami R,
Fujimori N, Higuchi K, Kudo M, Chiba Y, Kitano M.
Endoscopic ultrasound-guided biliary drainage for malignant biliary obstruction with surgically altered anatomy: a multicenter prospective registration study
Therap Adv Gastroenterol. 2020 Jul 29;13:1756284820930964. doi: 10.1177/1756284820930964. eCollection 2020.
Ito T,
Fujimori N, Honma Y, Kudo A, Hijioka S, Katsushima S, Kimura Y, Fukutomi A, Hisamatsu S, Nakajima A, Shimatsu A.
Long-term safety and efficacy of lanreotide autogel in Japanese patients with neuroendocrine tumors: Final results of a phase II open-label extension study
Asia Pac J Clin Oncol. 2020 Aug 5. doi: 10.1111/ajco.13371. Online ahead of print.
Atsushi Masamune, Kazuhiro Kikuta, Kiyoshi Kume, Shin Hamada, Ichiro Tsuji, Yoshifumi Takeyama, Tooru Shimosegawa, Kazuichi Okazaki, Japan Pancreas Society
Nationwide epidemiological survey of chronic pancreatitis in Japan: introduction and validation of the new Japanese diagnostic criteria 2019
J Gastroenterol. 2020 Jul 16. doi: 10.1007/s00535-020-01704-9.
Masamune A, Kikuta K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K; Japan Pancreas Society.
Clinical practice of acute pancreatitis in Japan: An analysis of nationwide epidemiological survey in 2016.
Pancreatology. 2020 Jun;20(4):629-636. doi: 10.1016/j.pan.2020.04.013.
Fujimori N, Miki M, Lee L, Matsumoto K, Takamatsu Y, Takaoka T, Teramatsu K, Suehiro Y, Murakami M, Igarashi H, Oono T, Ohtsuka T, Nakamura M, Koga Y, Oda Y, Ito T, Ogawa Y.
Natural history and clinical outcomes of pancreatic neuroendocrine neoplasms based on the WHO 2017 classification; a single-center experience of 30 years.
Pancreatology. 20:709-715. 2020.
Masamune A, Kikuta K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K; Collaborators.
Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016.
J Gastroenterol. 2020 Apr;55(4):462-470. doi: 10.1007/s00535-019-01658-7.
Fujita N, Nishie A, Asayama Y, Ishigami K,
Fujimori N, Ito T, Honda H
Intravoxel incoherent motion magnetic resonance imaging for assessment of chronic pancreatitis with special focus on its early stage.
Acta Radiol. 2020 May;61(5):579-585. doi: 10.1177/0284185119872687.
Miki M, Oono T,
Fujimori N, Takaoka T, Kawabe K, Miyasaka Y, Ohtsuka T, Saito D, Nakamura M, Ohkawa Y, Oda Y, Suyama M, Ito T, Ogawa Y.
CLEC3A, MMP7, and LCN2 as Novel Markers for Predicting Recurrence in Resected G1 and G2 Pancreatic Neuroendocrine Tumors.
Cancer Med. 8:3748-3760. 2019
Miyasaka Y, Ohtsuka T, Kimura R, Matsuda R, Mori Y, Nakata K, Kakihara D,
Fujimori N, Ohno T, Oda Y, Nakamura M.
Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer Potentially Improves Survival and Facilitates Surgery.
Ann Surg Oncol. 26:1528-1534. 2019
Miki M,
Fujimori N, Oono T, Kawabe K, Ohno A, Matsumoto K, Teramatsu K, Tachibana Y, Ogawa Y.
Relapse patterns and predictors of IgG4-related diseases involved with autoimmune pancreatitis: A single-center retrospective study of 115 patients.
J Dig Dis. 20:152-158. 2019
Toriyama K, Hijioka S, Komoto I, Kobayashi N, Okusaka T, Ku Y, Sudo K, Furukawa M, Tachibana Y, Takahashi M, Yasuda H, Nakamori S, Honma Y, Kida M,
Fujimori N, Kashiwada T, Masui T, Ishii H, Tsuchiya Y, Isaji S, Mizuno N, Hara K, Sakamine M, Imamura M, Kagimura T, Ito T.
Study Protocol for Prospective Observational Study 1 on the Prognosis of Patients with Unresectable Advanced Gastrointestinal and Pancreatic Neuroendocrine Tumors (PROP-UP 1 Study) in Japan.
J Clin Trials Vol 8(4) 2018
Ohtsuka T, Gotoh Y, Nakashima Y, Okayama Y, Nakamura S, Morita M, Aly MYF, Velasquez VVDM, Mori Y, Sadakari Y, Nakata K, Miyasaka Y, Ishigami K,
Fujimori N, Mochidome N, Oda Y, Shimizu S, Nakamura M.
Role of SpyGlass-DStm in the preoperative assessment of pancreatic intraductal papillary mucinous neoplasm involving the main pancreatic duct.
Pancreatology 18; 566-571, 2018.
Yasunaga K, Ito T, Miki M, Ueda K, Fujiyama T, Tachibana Y,
Fujimori N, Kawabe K, Ogawa Y.
Using CRISPR/Cas9 to Knock out Amylase in Acinar Cells.
Biomed Res Int 87:19397, 2018.
L Lee , Ito T, Igarashi H, Miki M,
Fujimori N, Kawabe K, Jensen RT, Ogawa Y.
Dose and schedule modification are required for long-term continuation of sunitinib in Japanese patients with advanced pancreatic neuroendocrine tumors.
Cancer Chemother Pharmacol. 81:163-169, 2018.
Ueda K, Kawabe K, Lee L, Tachibana Y,
Fujimori N, Igarashi H, Oda Y, Jensen RT, Takayanagi R, Ito T.
Diagnostic Performance of 48-Hour Fasting Test and Insulin Surrogates in Patients With Suspected Insulinoma.
Pancreas. 46:476-481, 2017
Niina Y, Ito T, Ueda K, Lee L, Igarashi H, Hijioka M, Takaoka T, Fujiyama T, Miki M, Tachibana Y,
Fujimori N, Ohtsuka T, Nakamura K, Kawabe K, Ogawa Y.
Effectiveness of endoscopic duodenal stenting for the management of patients with unresectable pancreatic cancer.
Gastroenterol Hepatol Endosc, 2: 1-5, 2017
Fujimori N, Osoegawa T, Lee L, Tachibana Y, Aso A, Kubo H, Kawabe K, Igarashi H, Nakamura K, Oda Y, Ito T.
Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors.
Scand J Gastroenterol 51: 245-252, 2016
Lee L, Igarashi H,
Fujimori N, Hijioka M, Kawabe K, Oda Y, Jensen RT, Ito T.
Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine tumors:a single-center retrospective study.
Jpn J Clin Oncol 45: 1131-1138, 2015
Kohjima M, Yoshimoto T, Enjoji M, Fukushima N, Fukuizumi K, Nakamura T, Kurokawa M,
Fujimori N, Sasaki Y, Shimonaka Y, Murata Y, Koyama S, Kawabe K, Haraguchi K, Sumida Y, Harada N, Kato M, Kotoh K, Nakamuta M.
Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver.
World J Gastroenterol. 21:3291-9, 2015
Hijioka M, Ito T, Igarashi H,
Fujimori N, Lee L, Nakamura T, Jensen RT, Takayanagi R.
Serum Chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumor.
Cancer Sci 105: 1464-1471, 2014
Niina Y, Ito T, Oono T, Nakamura T,
Fujimori N, Igarashi H, Sakai Y, Takayanagi R.
A sustained prostacyclin analog, ONO-1301, attenuates pancreatic fibrosis in experimental chronic pancreatitis induced by dibutyltin dichloride in rats.
Pancreatology. 14:201-10. 2014
Fujimori N, Igarashi H, Asou A, Kawabe K, Lee L, Oono T, Nakamura T, Niina Y, Hijioka M, Uchida M, Kotoh K, Nakamura K, Ito T, Takayanagi R.
Endoscopic approach through the minor papilla in the management of pancreatic diseases.
World J Gastrointest Endosc 5: 81-88, 2013
Uchida M, Ito T, Nakamura T, Igarashi H, Oono T,
Fujimori N, Kawabe K, Suzuki K, Jensen RT, Takayanagi R.
ERK pathway and sheddases play an essential role in ethanol-induced CX3CL1 release in pancreatic stellate cells.
Lab Invest.93:41-53. 2013
Nakamura T, Ito T, Igarashi H, Uchida M, Hijioka M, Oono T,
Fujimori N, Niina Y, Suzuki K, Jensen RT, Takayanagi R.
Cytosolic double-stranded DNA as a damage-associated molecular pattern induces the inflammatory response in rat pancreatic stellate cells: a plausible mechanism for tissue injury-associated pancreatitis.
Int J Inflam.2:504128.2012
Igarashi H, Ito T, Oono T, Nakamura T,
Fujimori N, Niina Y, Hijioka M, Uchida M, Lee R, Iwao R, Nakamura K, Kotoh K, Takayanagi R.
Relationship between pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4-related diseases.
J Dig Dis.13:274-9, 2012
Fujimori N, Oono T, Igarashi H, Ito T, Nakamura T, Uchida M, Coy DH, Jensen RT, Takayanagi R.
Vasoactive intestinal peptide reduces oxidative stress in pancreatic acinar cells through the inhibition of NADPH oxidase.
Peptides. 32:2067-76, 2011
Nakamura T, Ito T, Oono T, Igarashi H,
Fujimori N, Uchida M, Niina Y, Yasuda M, Suzuki K, Takayanagi R.
Bacterial DNA promotes proliferation of rat pancreatic stellate cells thorough toll-like receptor 9: potential mechanisms for bacterially induced fibrosis.
Pancreas. 40:823-31, 2011
Ito T, Nakamura T,
Fujimori N, Niina Y, Igarashi H, Oono T, Uchida M, Kawabe K, Takayanagi R, Nishimori I, Otsuki M, Shimosegawa T.
Characteristics of pancreatic diabetes in patients with autoimmune pancreatitis.
J Dig Dis. 12:210-6, 2011
Ito T, Otsuki M, Igarashi H, Kihara Y, Kawabe K, Nakamura T,
Fujimori N, Oono T, Takayanagi R, Shimosegawa T.
Epidemiological Study of Pancreatic Diabetes in Japan in 2005: A Nationwide Study.
Pancreas. 39:829-835, 2010
Gibo J, Ito T, Kawabe K, Hisano T, Inoue M, Fujimori N, Oono T, Arita Y and Nawata H.
Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity.
Lab Invest. 85:75-89, 2005